Nasdaq

Vigil Neuroscience, Inc. Reports Positive Phase 1 Data for VG-3927 and Outlines Upcoming Milestones in Alzheimer’s Disease and ALSP Treatment Programs

Vigil Neuroscience reported positive Phase 1 trial results for VG-3927 and plans a Phase 2 trial in Q3 2025. Vigil Neuroscience, Inc. announced promising outcomes from a Phase 1 clinical trial of ...
Bleacher Report

The Good, Bad and Ugly of 2025 MLB All-Star Game Phase 1 Voting Results

The 2025 MLB All-Star Game is just a few short weeks away, with the baseball world set to converge on Truist Park in Atlanta for the annual exhibition of the game's best and brightest. Phase 1 of the ...
Comicbook.com

10 Weird Things You Only Notice Rewatching the MCU’s Phase 1 in 2025

Click to share on X (Opens in new window) X Click to share on Facebook (Opens in new window) Facebook In the years since, the franchise has changed considerably. The MCU movies of 2025 have brought ...
Nasdaq

Kymera Therapeutics Reports Positive Phase 1 Results for KT-621, a Once-Daily Oral STAT6 Degrader, Surpassing Targets and Demonstrating Strong Safety Profile

Kymera's KT-621 shows promising STAT6 degradation in Phase 1 trials, with favorable safety and planned further studies in 2025. KT-621 demonstrated superior Th2 biomarker reductions compared to ...